As RSV cases rise, health experts urge vaccinations for pregnant women and at-risk populations. Learn how to protect your little ones this respiratory season.
Louisiana faces its worst whooping cough outbreak in 35 years, yet state health officials delayed critical vaccine alerts, raising concerns about public health responses and child safety.
A groundbreaking study shows that introducing peanut products to infants can lower the risk of developing peanut allergies by 43%. Discover how this could change pediatric dietary guidelines!
A groundbreaking study shows that introducing peanut products to infants as early as 4 months has led to a significant decline in peanut allergies among children, preventing around 60,000 cases. Experts emphasize the importance of early allergen exposure.
A decade after a groundbreaking study, new research reveals that early introduction of peanut products to infants has led to a significant decline in peanut allergies among children. This shift in guidelines is saving thousands of kids from life-threatening allergies.
While overall rates of sexually transmitted diseases in the U.S. have fallen, the alarming rise in congenital syphilis cases among newborns raises serious health concerns. Experts warn that we must do more to protect vulnerable populations.
In a race against time, Bear River Health officials moved swiftly to protect 11 exposed infants from measles, coordinating a vital response that involved notifying families and administering urgent treatments.
The American College of Obstetricians and Gynecologists has released updated guidance recommending COVID-19, influenza, and RSV vaccinations for pregnant women. These vaccines are shown to protect both mothers and infants from severe respiratory illnesses. Discover why vaccination is essential for a healthy pregnancy.
In a pivotal ruling, a federal judge in New Hampshire granted class-action status to a lawsuit challenging Trump's birthright citizenship order, temporarily blocking its implementation. This decision aims to protect the rights of children born in the U.S. amid ongoing legal battles.
In a groundbreaking move, Novartis has received approval for Coartem® Baby, the first malaria treatment specifically designed for newborns and young infants, addressing a critical healthcare gap in malaria-endemic regions.
